bioMérieux S.A. (BMXMF)
USD 103.09
(0.0%)
USD 103.09
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 445.4 Million | 475.1 Million | 811.1 Million | 582.8 Million | 407.9 Million | 386.9 Million |
| Net Income | 357.6 Million | 440.5 Million | 598.2 Million | 402.7 Million | 269.7 Million | 255.5 Million |
| Depreciation & Amortization | 389 Million | 277 Million | 231 Million | 210.8 Million | 189.5 Million | 157.9 Million |
| Deferred income taxes | -1 Billion | -95.9 Million | -18.1 Million | -2.2 Million | -32.6 Million | -67.5 Million |
| Stock-based compensation | 19.7 Million | 13 Million | 12.4 Million | 9.9 Million | 9.4 Million | 6.7 Million |
| Change in working capital | -203.3 Million | -155.9 Million | -36.4 Million | -80.7 Million | -66.9 Million | -1.6 Million |
| Other non-cash items | 883 Million | -3.6 Million | 24 Million | 42.3 Million | 38.8 Million | 35.9 Million |
| Investing Cash Flow | -488.8 Million | -528.1 Million | -307.3 Million | -265.2 Million | -282.2 Million | -418.2 Million |
| Investments in PPE | -338.3 Million | -286.7 Million | -290.1 Million | -277.5 Million | -272.5 Million | -226.8 Million |
| Acquisitions | -152.29 Million | -43.3 Million | -3.3 Million | -6.3 Million | 48.4 Million | -186.7 Million |
| Investment purchases | - | -10.5 Million | -400 Thousand | -2.3 Million | -2.4 Million | - |
| Sales/Maturities of investments | 1.8 Million | 17.4 Million | 20 Million | 24.7 Million | 17.1 Million | - |
| Other Investing Activities | -1.00 | -205 Million | -33.5 Million | -3.8 Million | -72.8 Million | -4.7 Million |
| Financing Cash Flow | -122.3 Million | -244.2 Million | -127 Million | -176.2 Million | -133.9 Million | 52.7 Million |
| Debt repayment | -34.8 Million | -53.4 Million | -68.3 Million | -426.5 Million | -69.1 Million | -105.5 Million |
| Dividends payments | -100.2 Million | -101.2 Million | -73.1 Million | -22.5 Million | -41.3 Million | -40.2 Million |
| Common Stock Repurchased | - | -157.2 Million | -3.8 Million | -18.4 Million | - | -22.3 Million |
| Common Stock Issuance | 12.7 Million | 67.7 Million | - | 292 Million | - | -83.2 Million |
| Other Financing Activities | 12.7 Million | -100 Thousand | 18.2 Million | -800 Thousand | -23.5 Million | 303.9 Million |
| Accounts receivables | -13.7 Million | -145.6 Million | 23.6 Million | -80.4 Million | -57.3 Million | -30.6 Million |
| Accounts payables | 3.4 Million | 9.9 Million | 24.2 Million | 4.7 Million | 32.9 Million | 13.1 Million |
| Inventory | -192.6 Million | -92.1 Million | -62.4 Million | -82.9 Million | -71 Million | -27.3 Million |
| Other working capital | -400 Thousand | 71.9 Million | -21.8 Million | 77.9 Million | 28.5 Million | 43.2 Million |
| Cash at beginning of period | 552.6 Million | 787.3 Million | 371.3 Million | 264 Million | 278.2 Million | 260.4 Million |
| Cash at end of period | 352.4 Million | 528.7 Million | 787.3 Million | 371.3 Million | 264 Million | 270 Million |
| Capital Expenditure | -338.3 Million | -286.7 Million | -290.1 Million | -277.5 Million | -272.5 Million | -226.8 Million |
| Effect of forex changes on cash | -29.7 Million | 38.7 Million | 39.2 Million | -34.1 Million | -6.1 Million | -11.8 Million |
| Net cash flow / Change in cash | -200.2 Million | -258.6 Million | 416 Million | 107.3 Million | -14.2 Million | 9.6 Million |
| Free Cash Flow | 107.1 Million | 188.4 Million | 521 Million | 305.3 Million | 135.4 Million | 160.1 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 215.3 Million | 357.6 Million | 196 Million | 161.6 Million | 440.5 Million | 224.3 Million |
| Depreciation & Amortization | 136.1 Million | 389 Million | 202.4 Million | 186.6 Million | 277 Million | 161.3 Million |
| Deferred income taxes | - | -1 Billion | -81 Million | -446.89 Million | -95.9 Million | -67.9 Million |
| Stock-based compensation | 11.3 Million | 19.7 Million | 11.5 Million | 8.19 Million | 13 Million | 8.3 Million |
| Change in working capital | -59.1 Million | -203.3 Million | -53.3 Million | -150 Million | -155.9 Million | -49.7 Million |
| Other non-cash items | -106.5 Million | 883 Million | 575.6 Million | 388.4 Million | -3.6 Million | 539.1 Million |
| Investing Cash Flow | -168.1 Million | -488.8 Million | -342 Million | -146.8 Million | -528.1 Million | -175.8 Million |
| Investments in PPE | -150.2 Million | -338.3 Million | -188 Million | -150.3 Million | -286.7 Million | -133.9 Million |
| Acquisitions | -8.8 Million | -152.29 Million | -155.1 Million | 2.8 Million | -43.3 Million | -38 Million |
| Investment purchases | -100 Thousand | - | 300 Thousand | -300 Thousand | -10.5 Million | -3.9 Million |
| Sales/Maturities of investments | - | 1.8 Million | 700 Thousand | 1.1 Million | 17.4 Million | 41.9 Million |
| Other Investing Activities | -9.1 Million | -1.00 | -154 Million | 3.5 Million | -205 Million | -35.5 Million |
| Financing Cash Flow | -115.3 Million | -122.3 Million | -16.2 Million | -106.1 Million | -244.2 Million | -116.4 Million |
| Debt repayment | -6.2 Million | -34.8 Million | -11.6 Million | -23.2 Million | -53.4 Million | -70.6 Million |
| Dividends payments | -100.2 Million | -100.2 Million | - | -100.2 Million | -101.2 Million | - |
| Common Stock Repurchased | -21.2 Million | - | -4.6 Million | - | -157.2 Million | -45.9 Million |
| Common Stock Issuance | - | 12.7 Million | -4.6 Million | 17.3 Million | 67.7 Million | - |
| Other Financing Activities | -100 Thousand | 12.7 Million | -11.6 Million | 17.3 Million | -100 Thousand | -70.6 Million |
| Accounts receivables | 34.9 Million | -13.7 Million | -78.1 Million | 64.4 Million | -145.6 Million | -133.1 Million |
| Accounts payables | -45 Million | 3.4 Million | 18.5 Million | -15.1 Million | 9.9 Million | 20.9 Million |
| Inventory | -83.9 Million | -192.6 Million | -77.8 Million | -114.8 Million | -92.1 Million | -48.1 Million |
| Other working capital | -10.1 Million | -400 Thousand | 84.1 Million | -84.5 Million | 71.9 Million | 110.6 Million |
| Cash at beginning of period | 352.4 Million | 552.6 Million | 423 Million | 552.6 Million | 787.3 Million | 524.2 Million |
| Cash at end of period | 252.4 Million | 352.4 Million | 352.4 Million | 423 Million | 528.7 Million | 552.6 Million |
| Capital Expenditure | -150.2 Million | -338.3 Million | -188 Million | -150.3 Million | -286.7 Million | -133.9 Million |
| Effect of forex changes on cash | 5.4 Million | -29.7 Million | -6.7 Million | -23 Million | 38.7 Million | -16.5 Million |
| Net cash flow / Change in cash | -100 Million | -200.2 Million | -70.6 Million | -129.6 Million | -258.6 Million | 28.4 Million |
| Free Cash Flow | 46.9 Million | 107.1 Million | 109.5 Million | -2.4 Million | 188.4 Million | 190.3 Million |
7269
CHV
078000
6307
AIL
21STCENMGM